Loading clinical trials...
Loading clinical trials...
The purpose of the study is to assess the efficacy and the safety profile of the Neuro Cochlear Implant System (CIS) in adults with severe-to-profound hearing loss.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Oticon Medical
NCT06960616 · Deafness, Cochlear Hearing Loss
NCT04240561 · Hearing Loss, Sensorineural, Dementia of Alzheimer Type, and more
NCT06782308 · Tinnitus, Subjective, Tinnitus, Bilateral, and more
NCT07416292 · Hearing Disorders and Deafness
NCT06058767 · Hearing Loss, Hearing Disorders in Children, and more
Nova Scotia Hearing and Speech centres
Halifax
Ottawa Civic Hospital
Ottawa
CHU de Quebec - Université de Laval
Québec
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions